These in silico analyses demonstrate that the MST1R and TYRO3 receptors are significantly overexpressed in mesothelioma (Figure S4), confirming previous data regarding MET (10) and AXL (13, 14), and suggesting that all four receptors may be candidate targets for therapy in MPM. The gene discussed is MET; the disease is mesothelioma.